- Bruce H. Bernstein
- James P. Bonnamy
- William S. Boshnick*
- Jeffrey R. Bousquet
- Paul A. Braier, Ph.D.
- Jill M. Browning
- Michael J. Fink
- Neil F. Greenblum
- James A. Gromada
- Harry J. Gwinnell
- Shawn A. Hamidinia, Ph.D.
- Jeffrey H. Handelsman*
- Gary V. Harkcom*
- Linda J. Hodge
- Barry I. Hollander
- Sok K. Hong
- Ali M. Imam*
- Gary M. Jacobs
- William E. Lyddane
- Jonathan R. Miller*
- Daniel B. Moon
- Robert W. Mueller
- Sean C. Myers-Payne, Ph.D.
- Naoko Ohashi*
- Enoch E. Peavey
- P. Branko Pejic*
- William Pieprz
- Steven Pollicoff*
- John Preta*
- James L. Rowland
- Stephen M. Roylance
- Kenneth H. Salen
- Walter Schlapkohl, Ph.D.
- Bruce H. Stoner, Jr.
- Arnold Turk
- Christopher L. Wright, Ph.D.*
- Patent Agents
- Patent Specialists
Neil F. Greenblum
Firm Practice Areas/Practice Groups
Litigation and Trial
Portfolio Management and Due Diligence
Client Counseling, Licensing and Technology Transfer
USPTO Patent Examiner – 1973-1977 (food technology)
Cabinet Netter, Paris, France – 1976-1977
Patent Attorney – Greenblum and Bernstein, P.L.C. – 1978-present
U.S. Legal Update Editor, Journal of Generic Medicines (current)
Lecturer on U.S. IP litigation and strategy at the Centre D’etudes Internationales de la Propriete Industrielle (CEIPI), University of Strasbourg, France – 1998 – present
International Generic Pharmaceutical Alliance (IGPA) – organizer/panelist - preconference seminar – 2000-present
Organizer/panelist, annual meeting of the European Generic Medicine Association (EGA), 2007-present
Founded Greenblum and Bernstein, P.L.C. in 1978.
- Litigates in numerous Federal District Courts, cases involving, e.g.:
- Pharmaceutical / Medical Devices / Communications Software / Material
- Trade Secret / Technology Ownership Issues
- Bench and Jury trials
Applies USPTO, litigation and business experience in conducting due diligence and other studies relating to validity / infringement issues, and in providing guidance and strategy relating to portfolio management and valuation.
Professional Associations and MembershipsPTAB Bar Association
Greenblum, N., Fink, M., Roylance, S., Pejic, P.B., Myers- Payne, S.C., Braier, P. (2008). “Generic Drugs in a Changing Intellectual Property Landscape.” The Pharmaceutical Regulatory Process, Second Edition, pps. 143-180, Ira R. Berry and Robert P. Martin, eds., Informa Health Care
Greenblum, N., (2007). “What is Obvious?” 5 Journal of Generic Medicines 71-77.
“The Case for the Boutique Patent Firm” Neil F. Greenblum, IP Law 360, (January 11, 2007)
EducationCity College of New York, B.S. in Chemical Engineering (1973)
American University Washington College of Law, J.D. (1976)
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of Virginia
1977, District of Columbia
1990, Commonwealth of Virginia